Corrigendum to 'Population pharmacokinetics-based recommendations for a single delayed or missed dose of nusinersen': Neuromuscular Disorders 31 (2021) 310-318/doi: 10.1016/j.nmd.2021.02.014

Affiliations

• ¹ Biogen, Cambridge, MA, USA.
• ² Department of Pediatric Neurology, Catholic University, Rome, Italy.
• ³ Department of Neuropediatrics, University Hospital Bonn, Bonn, Germany.
• ⁴ Dubowitz Neuromuscular Centre, NIHR Great Ormond Street Hospital Biomedical Research Centre, UCL Great Ormond Street Institute of Child Health & Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
• ⁵ Department of Neurology, Sydney Children's Hospital and School of Women's and Children's Health, UNSW Medicine, Sydney, New South Wales, Australia.
• ⁶ Nuventra Pharma Sciences, Research Triangle Park, NC, USA.
• ⁷ Center for Experimental Neurotherapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA. Electronic address: richard.finkel@stjude.org.